News › Clinical Practice, Industry News, Patient Care

Fibroblast-Seeded HA Filler Maintains Outcomes for Up to Six Years

April 30, 2019

Patients who received a hyaluronic acid (HA)-based filler seeded with cultured fibroblasts for volume loss are maintaining their outcomes for up to six years, according to the results of long-term outcome study published online March 28, 2019 in JAMA Facial Plastic Surgery.Read more at MedEsthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Beyond Either/Or: Building Integrated Treatment Plans with Energy-Based Devices and Injectables
    • FDA Approves Belotero Volume and Belotero Intense
    • Ad IntellX Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • SafeLink Consulting Inc. Launches SafeLink360, Bringing Risk & Compliance Management and Expert Support Together in One Platform
    • TITAN Aesthetic Founder Mary Beth Hagen Transfers Ownership to Carrie Galpin
Advertisement